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To the Editor:
We read with interest the article by
Tsutani and colleagues.1 They aimed
to determine clinical predictors of
nodal involvement in stage IA lung
adenocarcinoma and successfully
identified that tumor size <0.8 cm
and maximum standardized uptake
value <1.5 are predictive for stage
N0 status. We would like to discuss
the following interesting items.
One of the most important indica-
tions for sublobar resection is the ab-
sence of nodal disease (ie, stage N0),
which is usually preoperatively investi-
gated by computed tomography (CT)
and positron emission tomography
(PET)–CTscan.2Amoreaccurate eval-
uation of nodal status can be obtained
by intraoperative nodal dissection
with frozen section, as reported by the
authors.1 However, the intraoperative
evaluation of every hilar and mediasti-
nal nodal station appears to be too diffi-
cult to be routinely performed in1148 The Journal of Thoracic andclinical practice. To avoid this, Tsutani
and colleagues identified 2 factors sta-
tistically significant for preoperative
prediction of N0 status. In particular,
it is remarkable that these 2 parameters
are easily achievable by the chest CT
and PET–CT scan that are always per-
formed when staging the disease of ev-
ery patient with lung cancer.
We work daily with patients who
should be excluded from surgery be-
cause their poor general health condi-
tions or advanced age strongly advise
against lobectomy. Tsutani and col-
leagues’ findings should be particularly
useful with these patients because they
allow clinicians to preoperatively de-
termine patients in which lobectomy
can be avoided and sublobar resection
with nodal sampling is enough. This
increases the number of candidates for
surgery.
Another item that we would like to
underline is that the chance to preopera-
tively determineN0 status and therefore
to plan a sublobar resection allows sur-
geons to understand the proper access
to adopt. In particular, the possibility
of performing a wedge resection with
nodal sampling should increase the
chance to perform video-assisted tho-
racic surgery,3 increasing once again
the number of candidates for surgery.
One more interesting point is that
tumors determined to be<0.8 cm or
with maximum standardized uptake
value<1.5 are characterized by a mi-
nor pathologic invasiveness and there-
fore are related to a better disease-free
survival after sublobar resection.
Finally,wehave 1 suggestion regard-
ing the technique used in PET–CT scan
for lesions affected by physiologic mo-
tion as pulmonary nodules. We suggest
the use of respiratory gating4 because
this method results in lesion volumes
closer to those assessed by CT and im-
proves measurements of tracer uptake.
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We are grateful for the letter by Baisi
and colleagues regarding our study,1
andwe are delighted by their thoughtful
insights into our results. We appreciate
their viewpoint that 2 parameters (solid
tumor size<0.8 cm on high-resolution
computed tomography [HRCT] or a
maximum standardized uptake volume
[SUVmax]<1.5 on 18F-fluorodeoxy-
glucose positron emission tomography–
computed tomography [PET–CT]) for
predictingnonodalmetastasis are easily
achievableby the chestCTandPET–CT
scan that are always performed in stag-
ing the disease of every patient with
lung cancer.2
Generally, clinical physicians mea-
sure tumor size according to the TNM
Classification of Malignant Tumors
(TNM) by including the ground-glass
opacity (GGO) components visualized
on HRCT. We have found3,4 that
Letters to the Editorin addition to the SUVmax found on
PET–CT,2 the predictive values of the
solid tumor size found on HRCT for
pathologic high-grade malignancy
and prognosis in patients with clinical
stage IA lung adenocarcinoma are
greater than those of whole tumor
size, including solid and GGO compo-
nents. We strongly recommend that
solid tumor size be used to determine
the T descriptor in the TNM classifica-
tion of lung cancer and should be de-
fined as the true tumor size in cases of
lung adenocarcinoma with a GGO
component visualized on HRCT.
The suggestion regarding a tech-
nique in PET–CT scan for lung lesions
affected by physiologic motion is jus-
tified. The difference between the CT
volume and the gated PET volume is
significantly less than the difference
between the CT volume and the un-
gated PET volume.5 Respiratory gat-
ing has the potential to enhance
imaging of organs in motion, such as
lungs, and although some additional
time is needed for setup and acquisi-
tion, it can be incorporated practically
and efficiently into clinical routine.
Alternatively, breath-holding might
be used during diagnostic PET–CT if
true respiratory gating is not available.
Our belief, based on our data, is that
the optimal surgical strategy for
cT1N0M0 adenocarcinomas can be
chosen using the solid tumor size
found onHRCTand anSUVmax found
on 18F-fluorodeoxyglucose PET–CT.
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CANCER STAGING? AWORD
OF WARNING
To the Editor:
We read with interest the recent ar-
ticle by Yendamuri and Demmy1 con-
cerning the field of our long-standing
scientific interest. We are glad that
they share our fascination with the
transcervical approach to the medias-
tinum; however, fascination with tech-
nique should not let us turn a blind eye
to other, perhaps more important,
aspects of surgery.
As the Yendamuri and Demmy1
stated, transcervical extended medias-
tinal lymphadenectomy (TEMLA) is
only used in a very few centers. We
therefore draw the attention of the sur-
gical community to some important
issues missed by the Yendamuri and
Demmy.1
Discussing complications ofTEMLA,
Yendamuri and Demmy1 only men-
tioned the recurrent laryngeal nerve
palsy in 2.3% of patients. This state-
ment may yield a false impression of
safety. In fact, the rate of complica-
tions is high: in the original article on
83 patients,2 it was 13.2% and apartof Thoracic and Cardiovascular Surgerfrom recurrent nerve palsy included
respiratory insufficiency, arrhythmia,
pneumothorax, and deterioration in
mental status. What is even more
important, general fitness of 21% of
patients deteriorated after TEMLA,
to the degree of making them medi-
cally unfit for operation, although all
were initially considered surgical
candidates.2
The next article, analyzing results
in 256 patients, showed a complication
rate of 11.3% with a mortality as high
as 1.2%. Again, more than 21% of the
176 node-negative patients became
unfit for surgery because of deteriora-
tion of their general condition.3
In an updated series of 587 patients
published 3 years later, the mortality
was 0.9%.4
Complications of TEMLA may be
severe. Apart from the recurrent nerve
palsy mentioned by Yendamuri and
Demmy,1 they include perforation of
themain bronchus, superior vena caval
laceration, left phrenic nerve palsy,
and injury to the innominate artery.
The least important drawback of the
TEMLA is its operative time, which
may be as long as 161 minutes.
The readers should be aware that
these results were achieved in a very
experienced center, by surgeons espe-
cially devoted to this technique. The
complication rate in less experienced
hands is likely to be even higher.
The first question to be answered is
whether it is acceptable to use a stag-
ing procedure that is associated with
mortality comparable to pulmonary
lobectomy. The second, equally im-
portant, question is whether it is ac-
ceptable to use a staging procedure
that makes 21% of patients unfit for
curative-intent surgery. The obvious
answer to both these questions is no.
A different consideration is the use
of transcervical lymph node dissection
as an element of curative-intent pul-
monary resection. If extended medias-
tinal lymphadenectomydoes influence
survival, this approach would be inter-
esting.Atpresent, there arenopublished
data in this regard. Also, data regardingy c Volume 145, Number 4 1149
